Advertisement
Screener

Design Therapeutics, Inc. (DSGN) ROA

Design Therapeutics, Inc. (DSGN) ROA

  • 2026-06-30: ROA -32.91%.
  • 2026-03-31: ROA -30.25%.
  • 2025-12-31: ROA -30.85%.
  • 2025-09-30: ROA -31.85%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-32.91%
2026-03-31-30.25%
2025-12-31-30.85%
2025-09-30-31.85%
2025-06-30-28.48%
2025-03-31-23.66%
2024-12-31-19.67%
2024-09-30-18.26%
2024-06-30-18.74%
2024-03-31-21.05%
2023-12-31-23.08%
2023-09-30-24.13%
2023-06-30-23.83%
2023-03-31-21.35%
2022-12-31-18.56%
2022-09-30-16.09%
2022-06-30-13.77%
2022-03-31-11.43%
2021-12-31-9.10%
2021-09-30-7.07%
2021-06-30-4.77%
2021-03-31-3.19%
2020-12-31-22.67%

Annual ROA

DateROA
2025-12-31-30.85%
2024-12-31-19.67%
2023-12-31-23.08%
2022-12-31-18.56%
2021-12-31-9.10%
2020-12-31-22.67%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
GERON CORP (GERN)United States$0.803B-12.14
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53